Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2007
10/11/2007WO2007035213A3 Transgenic ungulates expressing ctla4-ig and uses thereof
10/11/2007WO2007011777A3 Small animal model for hcv replication
10/11/2007WO2006044674A3 G-protein estrogen membrane receptor
10/11/2007WO2004056979A3 Recombinant virus production for the manufacturing of vaccines
10/11/2007WO2004007527A3 Secreted proteins
10/11/2007WO2000073422A9 Genetically modified plant cells and plants with an increased activity of an amylosucrase protein and a branching enzyme
10/11/2007US20070240243 Nucleic acid sequence for forming a transgenic plant with at least one of: tolerance to salt, cold weather, drought, low nitrogen conditions; crops
10/11/2007US20070240240 Altered metabolism
10/11/2007US20070240239 Axmi-003, a delta-endotoxin gene and methods for its use
10/11/2007US20070240237 Pesticidal Vip3 toxins toxin from Bacillus thuringiensis highly active against a wide range of lepidopteran insect pests is disclosed. The DNA encoding the pesticidal toxin; used to transform various prokaryotic and eukaryotic organisms to express the pesticidal toxin;crops; genetic engineering
10/11/2007US20070239136 Cardiac Conduction System Cells and Uses Thereof
10/11/2007US20070238869 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238686 Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal-Antisense Oligodeoxy-Nucleotides Targeting To Grb2 or Crk1
10/11/2007US20070238684 For an improved in vitro and in vivo transformation of particular cells, for example for somatic gene therapy; diagnosis, increased infectivity for cells of low susceptibility, such as haematopoietic cells
10/11/2007US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007US20070238682 Heat shock rna and its use in activation of heat shock transcription factor and treatment of cancer, inflammation, ischemia, neurodegeneration, age-related diseases, hiv infection, deafness, and related disorders
10/11/2007US20070238677 Pharmaceutical Composition Containing Hshrd3
10/11/2007US20070238675 Stem Cell Beacon
10/11/2007US20070238673 Ceramide derivatives as modulators of immunity and autoimmunity
10/11/2007US20070238663 Use of HMGB1 to promote stem cell migration and/or proliferation
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070238655 Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
10/11/2007US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007US20070238642 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same
10/11/2007US20070238640 Treating an inflammatory condition in an individual by administering an agent which inhibits the interaction between a Toll-like receptor 2 and a high mobility group B polypeptide; treating Crohn's disease, sepsis, rheumatoid arthritis, systemic lupus erythematosus, endotoxic shock, allograft rejection
10/11/2007US20070238638 Bak promoter expression system
10/11/2007US20070238195 Conformational and topological protein regulation
10/11/2007US20070238182 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/11/2007US20070238179 Cell Division and Proliferation Preferred Regulatory Elements and Uses Thereof
10/11/2007US20070238178 Cancer vaccines; infections from Retrovirus, Herpesvirus, Hepadenovirus, Poxvirus, Parvovirus, Papillomavirus, or Papovavirus; reduced side effects; a hairpin RNA having a double stranded region of between 11 to 30 nucleotides; gene expression inhibition
10/11/2007US20070238177 Devices and methods for tissue transplant and regeneration
10/11/2007US20070238176 Bioreactor design and process for engineering tissue from cells
10/11/2007US20070238175 Standardization of processes for culturing primary cells
10/11/2007US20070238174 Substrates
10/11/2007US20070238173 Laminate of Cultured Human Corneal Endothelial Cells Layer and Method for Manufacturing Same
10/11/2007US20070238172 Methods of isolating bipotent hepatic progenitor cells
10/11/2007US20070238171 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/11/2007US20070238170 If high levels of fibroblast growth factor are used in a medium with 4-aminobutyric acid, pipecolic acid, lithium and lipids, the stem cells will remain undifferentiated indefinitely; initiating a new line of stem cells without the use of feeder cells or conditioned medium, avoids use of animal cells
10/11/2007US20070238169 Cell sorter and culture system
10/11/2007US20070238168 Double mutant alpha-7 nicotinic acetylcholine receptor
10/11/2007US20070238167 Flat microfibers as matrices for cell growth
10/11/2007US20070238160 microorganism capable of making an isoprenoid by changing the carbon flux through geranyl pyrophosphate, farnesyl pyrophosphate, or geranylgeranyl pyrophosphate and synthesis of isopentenyl pyrophosphate from an isoprenoid pathway; production of farnesol and geranylgeraniol
10/11/2007US20070238159 Production of Isoprenoids
10/11/2007US20070238157 Production of Isoprenoids
10/11/2007US20070238156 Biocatalytic Manufacturing of (Meth) Acrylylcholine or 2-(N, N-Dimethylamino) Ethyl (Meth) Acrylate
10/11/2007US20070238154 Humanized antibodies that recognize beta-amyloid peptide
10/11/2007US20070238151 Novel compounds
10/11/2007US20070238150 Pro4356 polypeptides
10/11/2007US20070238144 non-destructive and dynamic means for determining the cell cycle position of living cells; methods for measuring the effect of a test agent on the cell cycle position
10/11/2007US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
10/11/2007US20070238135 Novel g-protein coupled receptor and dna sequences thereof
10/11/2007US20070238134 Cell cycle proteins associated with rad9, compositions and methods of use
10/11/2007US20070238130 Novel Metalloproteinases
10/11/2007US20070238127 Determining the presence of chronic myelogenous leukemia (CML) stem cells; beta -catenin; antitumor agents, anticancer agents
10/11/2007US20070238123 Method for determining cell cycle position
10/11/2007US20070238089 Particle patterning chip
10/11/2007US20070238088 Hydrophilic functionalized colloidal silica compositions, methods of making, and uses therefor
10/11/2007US20070237795 Cryopreservation of Haptenized Tumor Cells
10/11/2007US20070237793 Attenuated or mutated pasteurella for use as tool in developing bactericidal agents; immunotherapy; immunogens for vaccines
10/11/2007US20070237787 Methods for use of tslp and agonists and antagonists thereof
10/11/2007US20070237776 Binds to hIL-18R alpha with high affinity and by the ability to neutralize hIL-18 activity, including IL-18-induced interferon gamma expression and IL-18-induced cellular activation; sepsis; cardiovascular disorders; liver injury; arthritis, including rheumatoid arthritis; inflammatory bowel diseases
10/11/2007US20070237774 Method for using BOC/CDO to Modulate Hedgehog Signaling
10/11/2007US20070237769 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
10/11/2007US20070237764 Binding polypeptides with restricted diversity sequences
10/11/2007US20070237759 Antibodies that bind PAR-2
10/11/2007US20070237754 Transient immortalization
10/11/2007US20070237753 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
10/11/2007US20070237752 Methods and Compositions for Enhancing Engraftment of Hematopoietic Stem Cells
10/11/2007US20070237751 Human Cord Blood as a Source of Neural Tissue Repair of the Brain and Spinal Cord
10/11/2007US20070237748 Enhancement of oligodendrocyte differrentiation
10/11/2007US20070237747 Method for Increasing the Yield of Proliferating Primary Keratinocytes
10/11/2007US20070237713 PCan065 Antibody Compositions and Methods of Use
10/11/2007US20070237711 Method of Increasing Radiation Sensitivity by Inhibition of Beta One Integrin
10/11/2007DE10158523B4 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue
10/11/2007CA2648618A1 Novel anti-cd98 antibody
10/11/2007CA2648361A1 Three dimensional cell culture
10/11/2007CA2648332A1 A shape-based approach for scaffoldless tissue engineering
10/11/2007CA2648327A1 Tissue engineering with human embryonic stem cells
10/11/2007CA2648144A1 Method and device for treating or selecting cells
10/11/2007CA2647846A1 Method for control of blood kinetics of antibody
10/11/2007CA2645170A1 Culture medium containing kinase inhibitors, and uses thereof
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842909A1 Method for removing desired chromosome and tailor-made medical treatment utilizing the same
10/10/2007EP1842906A1 Glucose dehydrogenase
10/10/2007EP1842905A1 Method of inducing differentiation of embryo-stem cell into hepatocyte and hepatocyte induced by the method
10/10/2007EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007EP1841878A1 Method for the generation of virus producing cell lines and cell lines
10/10/2007EP1841877A2 Transgenic evaluation of activated mutant alleles of sos2 reveals a critical requirement for its kinase activity and c-terminal regulatory domain for salt tolerance in arabidopsis thaliana
10/10/2007EP1841865A2 Inducible sirna expression cassette and method of use
10/10/2007EP1841858A2 Methods for high efficiency survival/proliferation of human embyonic stem cells and human embyro survival in culture
10/10/2007EP1841857A1 Methods and compositions relating to embryonic stem cell lines
10/10/2007EP1841856A1 A method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability
10/10/2007EP1841795A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/10/2007EP1841462A2 Growth factor therapy mobilization of stem cells into the peripheral blood
10/10/2007EP1841449A2 Methods and compositions related to modulating the extracellular stem cell environment
10/10/2007EP1841438A1 Methods for the treatment of lysosomal storage disorders
1 ... 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 ... 1827